Citation Impact
Citing Papers
A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
2007
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis
2021 Standout
Optical coherence tomography angiography
2017 Standout
PlGF: A Multitasking Cytokine with Disease-Restricted Activity
2012
Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
2008
Role of N-acetylcysteine and GSH redox system on total and active MMP-2 in intestinal myofibroblasts of Crohn's disease patients
2012
Physiology and pathophysiology of matrix metalloproteases
2010
A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
2011
Diabetic retinopathy
2010 Standout
Retinal artery occlusion following intravitreal anti‐VEGF therapy
2009
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
2011 Standout
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
2013 Standout
A review of clinical trials of anti-VEGF agents for diabetic retinopathy
2010
Therapies for Macular Edema Associated with Central Retinal Vein Occlusion
2015
Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study
2015
Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial
2011
Protective effects of 6-ureido/thioureido-2,4,5-trimethylpyridin-3-ols against 4-hydroxynonenal-induced cell death in adult retinal pigment epithelial-19 cells
2017
Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy
2014
Protective Effects of Flavonoids in Acute Models of Light-Induced Retinal Degeneration
2020
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
TFOS DEWS II pathophysiology report
2017 Standout
RETINAL PIGMENT EPITHELIAL TEARS IN RANIBIZUMAB-TREATED EYES
2009
Diabetic Retinopathy
2012 Standout
INCIDENCE OF ACUTE ONSET ENDOPHTHALMITIS FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION
2008
Vascular endothelial growth factor in eye disease
2008 Standout
Microvascular Modifications in Diabetic Retinopathy
2011
The Collagen Family
2010 Standout
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation
2009
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
2010
Age-related macular degeneration
2018 Standout
Geographic Atrophy
2014
Automated detection of COVID-19 cases using deep neural networks with X-ray images
2020 Standout
Anterior segment uses of bevacizumab
2012
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
2013 StandoutNobel
Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy
2008
INCIDENCE OF HEMORRHAGIC COMPLICATIONS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) OR RANIBIZUMAB (LUCENTIS) INJECTIONS ON SYSTEMICALLY ANTICOAGULATED PATIENTS
2010
ULTRA-WIDEFIELD FUNDUS IMAGING
2016
Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin®) for AMD followed by controlateral sympathetic ophthalmia
2009
Ranibizumab for Diabetic Macular Edema
2012 Standout
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
2011
Overviews of biological importance of quercetin: A bioactive flavonoid
2016 Standout
Progress in corneal wound healing
2015
Ocular delivery of proteins and peptides: Challenges and novel formulation approaches
2018
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up
2009
Hypoxia-Inducible Factor-Dependent Expression of Angiopoietin-Like 4 by Conjunctival Epithelial Cells Promotes the Angiogenic Phenotype of Pterygia.
2017 StandoutNobel
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Fluorosulfuryl Isocyanate Enabled SuFEx Ligation of Alcohols and Amines
2021 StandoutNobel
Hemorrhagic Macular Infarction After Intravitreal Bevacizumab for Central Retinal Vein Occlusion
2010
Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis.
1997
Quantum indistinguishability by path identity and with undetected photons
2022 StandoutNobel
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Automated segmentation of exudates, haemorrhages, microaneurysms using single convolutional neural network
2017
Silibinin inhibits VEGF secretion and age‐related macular degeneration in a hypoxia‐dependent manner through the PI ‐3 kinase/Akt /mTOR pathway
2012
DISEASE CLASSIFICATION OF MACULAR OPTICAL COHERENCE TOMOGRAPHY SCANS USING DEEP LEARNING SOFTWARE
2019
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Flavonoids as Potential Anti-Inflammatory Molecules: A Review
2022 Standout
Fluorosulfuryl Isocyanate Enabled SuFEx Ligation of Alcohols and Amines
2021 StandoutNobel
The effect of quercetin supplementation on selected markers of inflammation and oxidative stress.
2012
Retinal Pigment Epithelial Detachments in Age-Related Macular Degeneration: Classification and Therapeutic Options
2011
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Armin Wolf being referenced
Microaneurysm Turnover in Diabetic Retinopathy Assessed by Automated RetmarkerDR Image Analysis - Potential Role as Biomarker of Response to Ranibizumab Treatment
2014
Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF
2010
INTRAVITREAL BEVACIZUMAB INJECTIONS FOR TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION
2007
Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema
2012
Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma
2011
Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion
2008
Intravitreale Anti-VEGF-Behandlung retinaler angiomatöser Proliferationen
2008
Immunohistochemical Findings After LASIK Confirm In Vitro LASIK Model
2006
Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency
2011
The Protective Effect of Quercetin against Oxidative Stress in the Human RPE In Vitro
2008
Retinale Pigmentepithelrisse nach intravitrealem Bevacizumab bei AMD
2007
Megahertz ultra-wide-field swept-source retina optical coherence tomography compared to current existing imaging devices
2014
Visual acuity and central retinal thickness: fulfilment of retreatment criteria for recurrent neovascular AMD in routine clinical care
2014
INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMA
2006
Oxidative Stress-Mediated Induction of MMP-1 and MMP-3 in Human RPE Cells
2009
Combined 60° Wide-Field Choroidal Thickness Maps and High-Definition En Face Vasculature Visualization Using Swept-Source Megahertz OCT at 1050 nm
2015